News
MaaT Pharma to Present at H.C. Wainwright BioConnect 2022 Virtual Conference
Regulatory News:
MaaT Pharma (EURONEXT: MAAT - the “Company“), a French clinical-stage biotech and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving
Interactive Brokers Group Reports Brokerage Metrics and Other Financial Information for December 2021, includes Reg.-NMS Execution Statistics
Interactive Brokers Group, Inc. (Nasdaq: IBKR) an automated global electronic broker, today reported its Electronic Brokerage monthly performance metrics for December.
Brokerage highlights for
Intevac Announces Sale of Photonics Business
Intevac, Inc. (Nasdaq: IVAC), (“Intevac” or the “Company), a leading supplier of thin-film processing systems, today announced the sale of its Photonics business (“Photonics”) to EOTECH LLC, a
ABIONYX Pharma Announces That the French Drug Safety Agency (Agence Nationale de Sécurité du Médicament or ANSM) Has Granted a Compassionate Access Authorization for the bio-HDL (CER-001) in COVID-19 Disease
ABIONYX Pharma (FR0012616852 – ABNX – PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today announces that the
Ecovyst Inc. Appoints Christopher Evans to Lead Investor Relations
Ecovyst Inc. (NYSE: ECVT) (“Ecovyst”), a leading integrated and innovative global provider of specialty catalysts and services, today announced that it has appointed Christopher Evans to lead
Vancouver Clinic and Humana Introduce New Primary Care Practice Designed to Enhance Medicare Advantage Experience
Vancouver Clinic and Humana have teamed up to bring additional access to patient-focused primary care to Gresham, Oregon. Enliven by Vancouver Clinic (Enliven) recently opened its doors for the
MedMen Announces Termination of Investment Agreement
MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, today announced its termination of that certain
Exelon to Host Investor and Analyst Events for Exelon and Constellation to Discuss Post-Separation Strategies
Exelon Corp. (Nasdaq: EXC) today announced that it will host virtual investor and analyst events to highlight the post-separation business strategies for Exelon and Constellation.
Exelon’s event
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster dose of the
Marsh McLennan to Host Fourth Quarter Earnings Investor Call on January 27
Marsh McLennan (NYSE: MMC), the world’s leading professional services firm in the areas of risk, strategy and people, plans to announce fourth quarter financial results via news release on
Insperity and UnitedHealthcare Extend Relationship through 2026
Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America’s best businesses, today announced an extension of its 20-year relationship for
RealWear Selects Kopin Golden Pearl Microdisplay and Optics Display Module for RealWear Navigator™ 500
Kopin® Corporation (NASDAQ: KOPN), a leading provider of high-resolution microdisplays for Augmented Reality (AR) and Virtual Reality (VR), today announced that it is supplying RealWear, the
The Container Store Expands Its Custom Closet Offering With the Acquisition of Closet Works
The Container Store (the “Company”), the leading specialty retailer of storage and organization solutions and custom closets, today announced the acquisition of Chicago-based home storage solutions
Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Victory Capital Closes Acquisition of WestEnd Advisors
Victory Capital Holdings, Inc. (NASDAQ: VCTR) (“Victory Capital”) today announced that it successfully closed the previously announced acquisition of WestEnd Advisors (“WestEnd”) on December 31
Deciphera Pharmaceuticals, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference
Perion Network to Present at the 24th Annual Needham Growth Conference on January 12-13, 2022
Perion Network Ltd. (NASDAQ:PERI) a global advertising technology company that delivers holistic solutions across the three main pillars of digital advertising – ad search, social media and display
DGAP-News: Evotec receives € 7.5 m grant for development of COVID-19 therapeutic
EQS-News: Julius Baer Group to sell Wergen & Partner Wealth Management Ltd in a management buyout
DGAP-News: Deutsche Wohnen SE: Deutsche Wohnen with new members of Management Board and Supervisory Board
Gold Reserve Announces Retirement of Chief Financial Officer
Gold Reserve Inc. (TSX.V: GRZ) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announced that Robert A. McGuinness, the Company’s Vice President -Finance and Chief Financial Officer, has retired